These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Butylated hydroxytoluene exposure is necessary to induce lung tumors in BALB mice treated with 3-methylcholanthrene. Malkinson AM, Koski KM, Evans WA, Festing MF. Cancer Res; 1997 Jul 15; 57(14):2832-4. PubMed ID: 9230183 [Abstract] [Full Text] [Related]
3. Pharmacologic and genetic studies on the modulatory effects of butylated hydroxytoluene on mouse lung adenoma formation. Malkinson AM, Beer DS. J Natl Cancer Inst; 1984 Oct 15; 73(4):925-33. PubMed ID: 6592388 [Abstract] [Full Text] [Related]
5. Toxico-kinetic aspects of butylated hydroxytoluene (BHT): a review. Jori A. Ann Ist Super Sanita; 1983 Oct 15; 19(2-3):271-86. PubMed ID: 6398643 [No Abstract] [Full Text] [Related]
8. Enhanced acute lung damage in mice following administration of 1,3-bis(2-chloroethyl)-1-nitrosourea. Kehrer JP, Klein-Szanto AJ. Cancer Res; 1985 Nov 15; 45(11 Pt 2):5707-13. PubMed ID: 4053044 [Abstract] [Full Text] [Related]
11. Carbonyl reductase inactivation may contribute to mouse lung tumor promotion by electrophilic metabolites of butylated hydroxytoluene: protein alkylation in vivo and in vitro. Shearn CT, Fritz KS, Meier BW, Kirichenko OV, Thompson JA. Chem Res Toxicol; 2008 Aug 15; 21(8):1631-41. PubMed ID: 18597497 [Abstract] [Full Text] [Related]
15. Different modifying response of butylated hydroxyanisole, butylated hydroxytoluene, and other antioxidants in N,N-dibutylnitrosamine esophagus and forestomach carcinogenesis of rats. Fukushima S, Sakata T, Tagawa Y, Shibata MA, Hirose M, Ito N. Cancer Res; 1987 Apr 15; 47(8):2113-6. PubMed ID: 3829000 [Abstract] [Full Text] [Related]